AFC-HD AMS Life Science Co Ltd

Chart & Performance

D1W1MN

P/E

9.62

P/S

0.40

EPS

89.05

Div Yield, %

3.50%

Shrs. gr., 5y

—

Rev. gr., 5y

13.18%

Revenues

30.19b

+18.01%

Net income

1.25b

+13.56%

CFO

1.54b

+77.99%

Dividend

Aug 28, 20250 JPY/sh

Profile

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and supplements. It plans, researches, develops, and processes, as well as completes dietary supplement and cosmetics. The company offers health foods in various forms, such as tablets, soft and hard capsules, granules, soft drinks, and jellies. Its cosmetic products include facial cleansing, lotions, milky lotions, makeup oils, cleansing creams, and liquid cosmetics.. The company also wholesales dietary supplements and cosmetics; collects health-related information; plans and produces TV commercials, TV shopping channels, and video packages; publishes health magazines; and operates day and night care center under the Hello House name, and prep school under the Hello Gakuen name. In addition, it sells dietary supplements and cosmetics through mail orders; operates Internet shops; offers Kanpou, a general practitioner medicine for medical care; and produces and sells health care merchandise. The company operates in Japan, rest of Asia, and internationally. The company was formerly known as AMS Life Science Co., Ltd. and changed its name to AFC-HD AMS Life Science Co., Ltd. in March 2010. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.

URL

http://www.ams-life.com/

IPO date

Mar 03, 2005

Employees

799

Domiciled in

Incorporated in

Valuation

Order:

Title JPY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title JPY in thousands, except ratios and share amounts	2024‑08	2023‑08	2022‑08	2021‑08	2020‑08	2019‑08	2018‑08	2017‑08	2016‑08	2015‑08
Income
Revenues	30,185,451 18.01%	25,579,009 11.23%	22,997,127 2.81%
Cost of revenue	19,693,596	23,927,189	21,832,988
Unusual Expense (Income)
NOPBT	10,491,855	1,651,820	1,164,139
NOPBT Margin	34.76%	6.46%	5.06%
Operating Taxes	665,397	439,356	497,922
Tax Rate	6.34%	26.60%	42.77%
NOPAT	9,826,458	1,212,464	666,217
Net income	1,252,067 13.56%	1,102,564 49.94%	735,353 -50.83%
Dividends	(418,804)	(385,107)	(421,999)
Dividend yield		3.44%	3.88%
Proceeds from repurchase of equity		(79,568)	(288,891)
BB yield		0.71%	2.66%
Debt
Debt current	9,598,513	8,218,895	6,998,833
Long-term debt	13,293,145	11,324,017	10,144,069
Deferred revenue
Other long-term liabilities	1,927,666	1,481,282	1,283,097
Net debt	10,718,579	7,820,755	5,916,112
Cash flow
Cash from operating activities	1,540,093	865,280	1,492,417
CAPEX	(3,406,797)	(1,939,681)	(957,971)
Cash from investing activities	(2,761,467)	(1,946,009)	(1,077,917)
Cash from financing activities	2,232,074	1,881,171	1,159,612
FCF	7,577,287	(1,907,926)	227,487
Balance
Cash	12,172,810	11,182,021	10,377,778
Long term investments	269	540,136	849,012
Excess cash	10,663,806	10,443,207	10,076,934
Stockholders' equity	11,571,097	10,769,753	10,110,306
Invested Capital	28,113,614	23,734,332	20,610,972
ROIC	37.90%	5.47%	3.35%
ROCE	26.90%	4.80%	3.76%
EV
Common stock shares outstanding		14,053	14,119
Price	833.00 4.65%	796.00 3.38%	770.00 -33.04%
Market cap		11,185,846 2.89%	10,871,990 -32.81%
EV		19,055,231	16,794,160
EBITDA	11,577,415	2,635,817	2,170,759
EV/EBITDA		7.23	7.74
Interest	101,271	57,555	57,591
Interest/NOPBT	0.97%	3.48%	4.95%